Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Introduction: P2 receptors.

Geoffrey Burnstock¹

¹Autonomic Neuroscience Institute, Royal Free and University College, Rowland Hill Street, London NW3 2PF, UK. g.burnstock@ucl.ac.uk

Current Topics in Medicinal Chemistry

|April 14, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025

Same author

Two Distinct P2Y Receptors Are Involved in Purine- and Pyrimidine-Evoked Ca<sup>2+</sup> Elevation in Mammalian Brain Astrocytic Cultures.

Drug development research·2024

Same author

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.

British journal of pharmacology·2023

Same author

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors.

British journal of pharmacology·2021

Same author

Transient expression of thyrotropin releasing hormone peptide and mRNA in the rat hippocampus following global cerebral ischemia/reperfusion injury.

The International journal of neuroscience·2020

Same author

Purinergic Signaling and Related Biomarkers in Depression.

Brain sciences·2020

Same journal

Cosmetic Products Containing Rutin: A Systematic Review of Patents from 2014 to 2024.

Current topics in medicinal chemistry·2026

Same journal

Overview of Immunotherapy in Lung Cancer: Present Landscape.

Current topics in medicinal chemistry·2026

Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026

Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026

Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026

Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026

See all related articles

This review covers purinoceptors (P2X and P2Y receptors), detailing their roles in various diseases. It explores their potential as therapeutic targets for conditions like cardiovascular diseases, inflammation, and cancer.

Area of Science:

Pharmacology
Neuroscience
Molecular Biology

Background:

Purinergic signaling involves P2X (ligand-gated ion channels) and P2Y (G protein-coupled) receptors.
These receptors play crucial roles in numerous physiological and pathological processes.

Purpose of the Study:

To describe the current understanding of P2X and P2Y receptor subtypes.
To summarize their distribution and functions.
To explore their therapeutic potential across diverse diseases.

Main Methods:

Literature review and synthesis of existing research on purinoceptors.
Analysis of receptor distribution and functional roles.
Identification of potential therapeutic applications.

Related Experiment Videos

Main Results:

Detailed overview of P2X and P2Y receptor subtypes.
Summary of their involvement in cardiovascular, nervous, respiratory, and other systems.
Identification of purinoceptors as targets for diseases including inflammation, cancer, and diabetes.

Conclusions:

Purinoceptors represent significant therapeutic targets for a wide range of diseases.
Future research in purinergic signaling holds promise for novel treatments.